Eli Lilly

Eli Lilly and Company, founded in 1876, is a prominent American pharmaceutical firm engaged in the discovery, development, manufacture, and sale of a wide range of pharmaceutical products. The company operates facilities in the United States, Puerto Rico, and 25 other countries, distributing its products in approximately 135 countries worldwide. Eli Lilly's product portfolio includes treatments for various medical conditions, particularly in the fields of neurosciences and endocrinology. Notable products include Zyprexa for schizophrenia and bipolar disorder, Cymbalta for depression and anxiety, and Humalog for diabetes management. In addition to its pharmaceutical business, Eli Lilly also conducts research aimed at improving animal health and food production efficiency. The Eli Lilly Foundation further supports community initiatives focused on enhancing patient outcomes and educational opportunities, particularly in underserved areas.

Patrick Cassidy

Director, Treasury Operations

Mike Czapar

Director of Investor Relations

Vicky Erwin

Investment Director, Pension and Benefits

David A. Ricks

Chairman and Chief Executive Officer

Susan Ridlen

Assistant Treasurer and Chief Investment Officer, Retiree Benefit Plans

Joshua Smiley

Senior Vice President and Chief Financial Officer

James Ward

Vice President and Chief Financial Officer International

Shawn Winnie

Director of Investments, Private Markets

Past deals in Indiana

Indianapolis Cultural Trail operates as a 501c3 nonprofit organization that engages in urban trails and linear parks and is committed to a sustainable funding model that ensures accessible connections for future generations.